About Kaps3
Kaps3 is a Healthcare company based in Surendranagar (India) founded in 2018. Pharmaceutical product manufacturing and distribution in India. Its Indian entity Kaps Three Life Sciences Private Limited reported revenue of ₹14.11 Cr. Kaps3 offers products and services including BRONCOZA and ESOCITA-C TAB. Its focus areas include Nutraceuticals, Health Supplements, Nutritional Products and Pharmaceuticals.
Company details
Kaps3 Lifesciences Pvt. Ltd. is recognized as a rising entity in the pharmaceutical sector, having been established through the collaborative efforts of six professionals. A commitment to providing high-quality products at affordable rates is maintained, with strict quality checks performed by experienced teams to ensure adherence to international standards. Innovative efforts are focused on product development and packaging, leading to the companys rapid gain of market position. A wide range of pharmaceutical offerings, including treatments for coughs and other conditions, is provided, contributing to its prominence within a short period.
- Headquarters Surendranagar, India
- SectorsHealthcare
- Phone•••• ••••
- Social X Facebook Instagram YouTube
- Legal Name Kaps Three Life Sciences Private Limited
- Date of Incorporation 23 Nov, 2011
- Jurisdiction Surendranagar, Gujarat, India
- Annual Revenue₹14.11 Cr
FY 2026 · -2% YoY
- Net Profit₹6.3 Lakh
FY 2026 · 0% margin
- EBITDA₹12.9 Lakh
FY 2026 · 1% margin
Associated legal entities of Kaps3
Kaps3 operates through Kaps Three Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kaps Three Life Sciences Private Limited CIN U24232GJ2011PTC092127 | Active | 23 Nov 2011 | Surendranagar, Gujarat | ₹14.1 Cr | 6 | View details |
Products & Services of Kaps3
Kaps3 offers a comprehensive portfolio of products and services, including BRONCOZA and ESOCITA-C TAB.
A non-addictive antitussive medication that is used for dry coughs
A product that is provided for health purposes, as indicated in product updates
Apps and channels of Kaps3
its YouTube channel Kaps Three Lifesciences Pvt. Ltd has 252 subscribers and 15 videos.
Videos from Kaps3
The most watched videos on Kaps3's YouTube channel, Kaps Three Lifesciences Pvt. Ltd (252 subscribers). Click a video to play it here.
More on Kaps Three Lifesciences Pvt. Ltd.
Board of directors of Kaps Three Life Sciences Private Limited (Kaps3)
Kaps Three Life Sciences Private Limited is the primary company behind Kaps3. The board of Kaps Three Life Sciences Private Limited currently have 6 directors; the longest-serving is Vinayak Rameshpkamat Kamat, appointed in 2011.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vinayak Rameshpkamat Kamat DIN 03559641 | Director | 23 Nov 2011 | 14 yrs 11 mo | Kaps Three Life Sciences Private Limited |
| Prashantbhai Popatlal Shah DIN 03552736 | Director | 23 Nov 2011 | 14 yrs 11 mo | Kaps Three Life Sciences Private Limited |
| Vikas Pandey DIN 03556866 | Director | 23 Nov 2011 | 14 yrs 11 mo | Kaps Three Life Sciences Private Limited |
| Kishor Ramesh Sharma DIN 03565173 | Director | 23 Nov 2011 | 14 yrs 11 mo | Kaps Three Life Sciences Private Limited |
| Arun Gupta DIN 03569055 | Director | 23 Nov 2011 | 14 yrs 11 mo | Kaps Three Life Sciences Private Limited |
| Santonu Shukla DIN 03548863 | Director | 23 Nov 2011 | 14 yrs 11 mo | Kaps Three Life Sciences Private Limited |
Financials of Kaps3
Figures of Kaps Three Life Sciences Private Limited, the primary company behind Kaps3, for FY 2026. Revenue was ₹14.11 Cr (-2% year on year). Net profit was ₹6.3 Lakh (0% margin). EBITDA was ₹12.9 Lakh (1% margin). Revenue has grown at a compounded annual rate of +5% over three years and +12% over five years.
- ₹14.11 CrRevenue · FY 2026 · -2% YoY
- ₹6.3 LakhNet profit · 0% margin
- ₹12.9 LakhEBITDA · 1% margin
- ₹80 LakhPaid-up capital
- +5%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kaps Three Life Sciences Private Limited are on its company page.
Detailed financial statements for Kaps3
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Kaps3
The website of Kaps3 (kaps3.co.in) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 18.4% vs previous month
Websites whose visitors overlap most with Kaps3. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ikonremedies.com | 100% | 12.3K | View details |
Top companies in Alternative Medicine Products
3 companies that operate in the same segment as Kaps3 (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Homeopathic medicine manufacturing and online retail in India. | 1898 | Noida, Uttar Pradesh, India | USD 26.35 M | 1,192 | ||
Operates an online store specializing in ayurvedic and homeopathic medicines. | 2016 | Delhi, Delhi, India | USD 1.25 M | 16 | ||
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness. | 1992 | Faridabad, Haryana, India | USD 10.08 M | 570 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kaps3
Kaps3 was founded in 2018.
Kaps3 is headquartered in Surendranagar, India. It is registered at Surendranagar, Gujarat, India.
The primary company behind Kaps3, Kaps Three Life Sciences Private Limited, reported revenue of ₹14.11 Cr for FY 2026, down 2% year on year.
Kaps3 Lifesciences Pvt. Ltd. is recognized as a rising entity in the pharmaceutical sector, having been established through the collaborative efforts of six professionals. A commitment to providing high-quality products at affordable rates is maintained, with strict quality checks performed by experienced teams to ensure adherence to international standards. Innovative efforts are focused on product development and packaging, leading to the companys rapid gain of market position. A wide range of pharmaceutical offerings, including treatments for coughs and other conditions, is provided, contributing to its prominence within a short period.
Kaps3 offers BRONCOZA and ESOCITA-C TAB.
Kaps3 operates through Kaps Three Life Sciences Private Limited.
The legal entities of Kaps3 currently have 6 directors, including Vinayak Rameshpkamat Kamat, Prashantbhai Popatlal Shah, Vikas Pandey and others.